Viewing Study NCT02855892


Ignite Creation Date: 2025-12-24 @ 3:42 PM
Ignite Modification Date: 2026-02-05 @ 7:24 AM
Study NCT ID: NCT02855892
Status: COMPLETED
Last Update Posted: 2022-03-04
First Post: 2016-08-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Patients With BPH
Sponsor: GemVax & Kael
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-10
Start Date Type: None
Primary Completion Date: 2016-10
Primary Completion Date Type: ACTUAL
Completion Date: 2016-10
Completion Date Type: ACTUAL
First Submit Date: 2016-08-01
First Submit QC Date: None
Study First Post Date: 2016-08-04
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-02-16
Last Update Post Date: 2022-03-04
Last Update Post Date Type: ACTUAL